Home> Products> optimal treatment outcomes

{ "products": [ { "_id": "6891f29bfb7044dfb2d43adf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MAGRAL 160", "description": "MAGRAL 160 is a pharmaceutical medication containing megestrol acetate 160 mg, a synthetic progestin known for its potent antineoplastic and appetite-stimulating properties. This drug is primarily prescribed to manage significant health challenges such as unexplained weight loss, anorexia, and cachexia, especially in patients suffering from chronic conditions like cancer or AIDS. Additionally, megestrol acetate functions as a hormone therapy agent employed in the treatment of certain hormone-sensitive malignancies. Its dual action both supports tumor management and improves patients' nutritional status by stimulating appetite and promoting weight gain, thereby enhancing overall quality of life. The drug is regarded as a crucial option in oncology and palliative care for managing complex conditions related to hormone-dependent cancers and severe wasting syndromes.\n\nWhat is MAGRAL 160?\nMAGRAL 160 is an oral medication formulated with megestrol acetate 160 mg, a synthetic progestin hormone derivative. It works primarily by modulating hormone receptors and altering hormone levels that influence the growth of hormone-responsive tumors such as breast and endometrial cancers. Apart from its antineoplastic action, it stimulates appetite by acting on the hypothalamic centers responsible for hunger, helping patients suffering from severe weight loss regain a healthy appetite and weight.\n\nUses of MAGRAL 160\n\nTo treat hormone-dependent cancers, specifically advanced breast cancer and endometrial cancer.\n\nTo stimulate appetite and promote weight gain in patients experiencing anorexia, cachexia, or unexplained severe weight loss related to chronic illnesses like cancer or AIDS.\n\nTo manage wasting syndromes that lead to malnutrition and significant weight loss.\n\nTo serve as an antineoplastic agent in hormone-sensitive malignancies.\n\nIn short, MAGRAL 160 is primarily used to treat anorexia and cachexia or serious unexplained weight loss and is also used as an antineoplastic agent to treat certain types of malignancy.\n\nSide Effects of MAGRAL 160\n\nWeight gain (often desirable but can be excessive)\n\nFluid retention and edema (swelling)\n\nNausea and vomiting\n\nDiarrhea or constipation\n\nVaginal bleeding or spotting in women\n\nFatigue, weakness, and insomnia\n\nHeadache and dizziness\n\nIncreased risk of blood clots (deep vein thrombosis or pulmonary embolism)\n\nHormonal imbalances, such as decreased sex hormone levels, which can lead to sexual dysfunction or bone density loss\n\nAllergic reactions including rash or itching\n\nPatients should report severe or unusual symptoms, especially signs of blood clots such as limb swelling, chest pain, or sudden shortness of breath, immediately to their healthcare provider.\n\nPrecautions before Using MAGRAL 160\n\nInform your doctor if you are pregnant, breastfeeding, or planning to conceive as MAGRAL 160 is contraindicated in pregnancy.\n\nDisclose any history of blood clots, cardiovascular diseases, liver or kidney impairment.\n\nPatients with diabetes should monitor blood sugar closely as megestrol acetate may cause hyperglycemia.\n\nAvoid sudden discontinuation without medical advice to prevent potential hormonal withdrawal effects.\n\nRegular monitoring is required, including hormone levels and blood tests, to assess efficacy and safety during treatment.\n\nUse cautiously in patients at risk for deep vein thrombosis or pulmonary embolism due to increased clotting risks.\n\nDrug Interactions: What Drugs Interact with MAGRAL 160?\n\nCYP3A4 enzyme inducers (e.g., rifampin, phenytoin) may reduce the effectiveness of megestrol acetate by increasing its metabolism.\n\nConcurrent use with blood thinners (anticoagulants) requires careful monitoring as MAGRAL 160 might influence clotting parameters.\n\nCombining with drugs that affect hormonal pathways, such as other hormonal therapies or corticosteroids, may alter treatment outcomes.\n\nInteractions with diabetes medications might necessitate dose adjustment due to potential effects on blood sugar control.\n\nCareful medical supervision is necessary when used with immunosuppressants or other chemotherapy agents to avoid additive side effects or altered drug levels.\n\nConclusion\nMAGRAL 160, containing megestrol acetate 160 mg, is a clinically validated medication widely used to manage complex conditions such as hormone-dependent cancers as well as severe weight loss due to anorexia and cachexia. Its unique ability to act both as an antineoplastic agent and an appetite stimulant makes it invaluable in improving patient outcomes, nutritional status, and overall quality of life. Patients prescribed MAGRAL 160 should adhere strictly to their healthcare provider’s instructions and report any adverse effects promptly. This medication should always be used under medical supervision to ensure optimal benefits and minimize risks.", "price": 810.0, "discountamount": 243.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2156, "imageuri": "https://productimages.withfloats.com/actual/6891f2a0115b51057b971998.png", "tileimageuri": "https://productimages.withfloats.com/tile/6891f2a0115b51057b971998.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-05T12:01:31.195Z", "updatedon": "2025-08-05T12:01:31.195Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/magral-160/2156", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "megestrol acetate 160 mg", "category": "Gynaecology", "tags": [ "megestrol acetate 160 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6880c5c93213965b404bd37e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SLO THEO TABLETS", "description": "SLO THEO Tablets is a combination respiratory medication containing Etophylline 231 mg and Theophylline 69 mg, specially formulated to provide effective and long-lasting relief from bronchospasm associated with asthma, bronchitis, and chronic obstructive pulmonary diseases (COPD). These tablets belong to the class of bronchodilators, which work by relaxing the muscles in the lungs and widening the airways to make breathing easier.\n\nTheophylline+etofylline contains two bronchodilators namely, Theophylline and Etofylline, used to treat symptoms of asthma and chronic obstructive pulmonary diseases (COPD).\n\nWhat is SLO THEO Tablet?\nSLO THEO Tablet is a prescription drug that combines etophylline and theophylline in a sustained-release form, helping to manage and control chronic breathing conditions. Etophylline enhances the solubility and bioavailability of theophylline, thereby improving therapeutic outcomes in patients with obstructive airway diseases.\n\nIt is particularly useful in patients who suffer from repeated asthma attacks or have difficulty breathing due to COPD. The medication is typically taken orally, and its slow-release mechanism ensures consistent bronchodilation over several hours.\n\nUses of Etophylline and Theophylline Tablets\nSLO THEO Tablets are primarily used for the prevention and treatment of:\n\nBronchial asthma\n\nChronic bronchitis\n\nEmphysema\n\nWheezing and shortness of breath\n\nChronic obstructive pulmonary disease (COPD)\n\nRespiratory distress due to airway narrowing\n\nBy relaxing the smooth muscles in the bronchial tubes, etophylline and theophylline tablets help in clearing air passages and improving airflow, thus reducing breathing effort and improving quality of life.\n\nSide Effects of SLO THEO Tablets\nWhile SLO THEO Tablets are generally well-tolerated, some individuals may experience certain side effects, especially when starting treatment or at higher doses:\n\nNausea and vomiting\n\nHeadache\n\nInsomnia or restlessness\n\nIncreased heartbeat (palpitations)\n\nDizziness or tremors\n\nStomach discomfort\n\nMuscle cramps\n\nIrritability or anxiety\n\nIf any of these symptoms persist or worsen, consult your doctor promptly. Serious allergic reactions are rare but require immediate medical attention.\n\nPrecautions Before Using SLO THEO Tablets\nBefore starting therapy with etophylline and theophylline tablets, discuss the following with your healthcare provider:\n\nInform if you have a history of heart disease, liver disorders, epilepsy, stomach ulcers, hyperthyroidism, or high blood pressure.\n\nUse with caution in elderly patients and those with weakened liver function.\n\nAvoid excessive consumption of caffeine-containing products (like coffee, tea, or energy drinks), as they may increase side effects.\n\nNot recommended for use during pregnancy or breastfeeding unless prescribed by a healthcare professional.\n\nDo not stop the medication suddenly without medical advice.\n\nDrug Interactions\nSLO THEO Tablets may interact with several other drugs, potentially affecting how either medicine works or increasing the risk of side effects. Always inform your doctor about all the medications and supplements you are taking.\n\nWhat drugs interact with etophylline and theophylline tablets?\n\nAntibiotics like ciprofloxacin, erythromycin\n\nAnti-seizure medications such as phenytoin and carbamazepine\n\nHeart medications like verapamil or propranolol\n\nDiuretics, especially furosemide\n\nOral contraceptives\n\nSmoking (which can reduce drug effectiveness)\n\nAnti-flu drugs like oseltamivir\n\nThese interactions can either raise the levels of theophylline in the blood or reduce its effectiveness, so regular monitoring and dose adjustment may be required.\n\nConclusion\nSLO THEO Tablets, containing etophylline 231 mg and theophylline 69 mg, offer a reliable solution for those suffering from obstructive airway diseases like asthma and COPD. The synergistic action of these bronchodilators helps in easing breathing, reducing wheezing, and preventing respiratory distress. Though effective, it is essential to take these tablets under medical supervision, especially if you are on other medications or have pre-existing health conditions.\n\nAlways follow your physician’s advice regarding dosage, frequency, and duration of treatment to ensure optimal therapeutic outcomes and minimize any potential risks associated with the use of etophylline and theophylline tablets.", "price": 90.0, "discountamount": 27.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2149, "imageuri": "https://productimages.withfloats.com/actual/6880c5d95b53b8e224cf86f3.png", "tileimageuri": "https://productimages.withfloats.com/tile/6880c5d95b53b8e224cf86f3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-23T11:21:45.632Z", "updatedon": "2025-07-23T11:40:59.364Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/slo-theo-tablets/2149", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "etophylline and theophylline tablets", "category": "ASTHMARANGE", "tags": [ "etophylline and theophylline tablets", "etophylline and theophylline tablets uses in hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6797579a56219bc105ead8ff", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Bisoprolol (5mg)", "description": "Bisoprolol 5mg\nBISOPROLIN 5 is a highly effective medication containing Bisoprolol 5mg, a beta-blocker that is widely used to manage various cardiovascular conditions. Bisoprolol is a selective beta-1 adrenergic receptor blocker, which helps in reducing heart rate, blood pressure, and the overall workload on the heart. It is commonly prescribed to treat conditions like hypertension (high blood pressure), chronic heart failure, and angina (chest pain). BISOPROLIN 5 is an essential component of heart disease management, designed to improve heart function, reduce symptoms, and prevent further complications.\n\nKey Uses of BISOPROLIN 5\n1. Management of Hypertension (High Blood Pressure)\nBISOPROLIN 5 is frequently prescribed for hypertension, as it effectively lowers high blood pressure, helping to reduce the risk of life-threatening complications such as heart attacks, strokes, and kidney damage. By blocking beta-1 receptors in the heart, it helps in lowering heart rate and blood pressure.\n\n2. Treatment of Chronic Heart Failure (CHF)\nChronic heart failure is a condition where the heart's ability to pump blood is impaired. BISOPROLIN 5 is commonly used to improve heart function and reduce symptoms of heart failure such as shortness of breath, swelling in the legs, and fatigue. By lowering the workload on the heart, it helps manage heart failure symptoms and prevent hospitalizations.\n\n3. Prevention of Angina (Chest Pain)\nBISOPROLIN 5 helps in managing angina by reducing the heart's oxygen demand, thus preventing episodes of chest pain caused by insufficient blood flow to the heart. It is especially beneficial in patients with stable angina or other ischemic heart conditions.\n\n4. Management of Cardiac Arrhythmias\nBISOPROLIN 5 is effective in managing cardiac arrhythmias (irregular heartbeats), particularly atrial fibrillation. It works by stabilizing the electrical activity in the heart and preventing abnormal rhythms, ensuring proper heart function.\n\nBenefits of BISOPROLIN 5\n1. Effective Blood Pressure Control\nBISOPROLIN 5 significantly helps in maintaining normal blood pressure levels. By reducing blood pressure, it helps prevent the complications associated with hypertension, such as heart attack, stroke, and kidney disease.\n\n2. Improvement in Heart Function\nFor patients suffering from heart failure, BISOPROLIN 5 helps to improve heart function by reducing the heart’s workload and optimizing its ability to pump blood. This results in a reduction of heart failure symptoms such as fatigue and fluid retention.\n\n3. Prevention of Angina Attacks\nFor those with angina, BISOPROLIN 5 helps prevent chest pain episodes and improves exercise tolerance by reducing the heart's oxygen demand.\n\n4. Reduced Risk of Cardiovascular Events\nBy lowering both blood pressure and heart rate, BISOPROLIN 5 helps reduce the risk of severe cardiovascular events like heart attacks and strokes.\n\nHow BISOPROLIN 5 Works\nBISOPROLIN 5 contains Bisoprolol, a beta-blocker that primarily affects the heart's beta-1 receptors. By binding to these receptors, Bisoprolol reduces the heart rate and the force of heart contractions. This helps the heart beat more efficiently and requires less oxygen, especially during periods of stress or activity. Additionally, Bisoprolol dilates blood vessels, leading to lower blood pressure.\n\nBy reducing the heart's workload, BISOPROLIN 5 not only manages hypertension and heart failure symptoms but also decreases the risk of arrhythmias and angina.\n\nDosage and Administration\nRecommended Dosage\nThe usual dose of BISOPROLIN 5 is 5mg once daily. The dose may vary depending on the condition being treated, the severity of the condition, and individual patient response. The medication is typically taken once a day, and it is important to follow the doctor's instructions for optimal results.\n\nHow to Take BISOPROLIN 5\nTake the tablet at the same time every day to ensure consistency.\nSwallow the tablet whole with water.\nBISOPROLIN 5 can be taken with or without food.\nDo not crush or chew the tablet.\nDo not stop taking the medication abruptly without consulting your healthcare provider, as this can worsen the condition.\nPossible Side Effects\nLike any medication, BISOPROLIN 5 may cause side effects. However, not everyone will experience them. Common side effects include:\n\nCommon Side Effects\nFatigue or Tiredness: Feeling excessively tired is a common side effect, especially in the initial stages of treatment.\nDizziness or Lightheadedness: This can occur, particularly when standing up quickly.\nSlow Heart Rate (Bradycardia): A reduced heart rate is a common effect of Bisoprolol.\nCold Extremities: Hands and feet may feel cold due to reduced blood flow.\nNausea or Upset Stomach: Mild stomach discomfort may be experienced.\nRare but Serious Side Effects\nSevere Bradycardia (Extremely Slow Heart Rate): If the heart rate drops too much, it may lead to fainting or severe dizziness.\nBreathing Problems: Difficulty breathing or wheezing, especially in individuals with asthma.\nSevere Allergic Reactions: Such as swelling of the face, lips, or throat.\nLiver Dysfunction: Signs of liver problems include jaundice, dark urine, or persistent nausea.\nIf any severe or persistent side effects occur, contact your healthcare provider immediately.\n\nDrug Interactions\nBISOPROLIN 5 may interact with certain medications, affecting its effectiveness or increasing the risk of side effects. Some common drug interactions include:\n\nOther Blood Pressure-Lowering Drugs: Combining BISOPROLIN 5 with other antihypertensive medications (e.g., calcium channel blockers or ACE inhibitors) may lead to excessively low blood pressure.\nAnti-arrhythmic Drugs: Medications for heart rhythm disorders, such as amiodarone or sotalol, may interact with Bisoprolol.\nInsulin or Oral Diabetes Medications: Bisoprolol can mask the symptoms of low blood sugar (hypoglycemia), so extra monitoring is needed in diabetic patients.\nNSAIDs (Non-Steroidal Anti-Inflammatory Drugs): These may reduce the blood pressure-lowering effect of BISOPROLIN 5.\nAntidepressants or Antipsychotics: Certain psychiatric medications may enhance Bisoprolol’s side effects, such as dizziness and fatigue.\nAlways inform your healthcare provider about all medications, supplements, and over-the-counter drugs you are currently taking.\n\nPrecautions and Warnings\n1. Who Should Avoid BISOPROLIN 5?\nPeople with severe asthma, COPD (Chronic Obstructive Pulmonary Disease), or other respiratory disorders.\nIndividuals with a history of heart block or very low heart rate (bradycardia).\nThose with uncontrolled heart failure or shock.\n2. Pregnancy and Breastfeeding\nBISOPROLIN 5 should only be used during pregnancy if absolutely necessary. It is not recommended for breastfeeding mothers, as it may pass into breast milk.\n\n3. Regular Monitoring\nIt is important to regularly monitor blood pressure and heart rate while taking BISOPROLIN 5. Liver and kidney function may also need to be checked periodically.\n\nLifestyle and Dietary Tips\nFollow a healthy, balanced diet with limited salt intake to support heart health.\nExercise regularly as recommended by your doctor, but avoid strenuous activity without proper consultation.\nLimit alcohol consumption to reduce potential interactions and side effects.\nQuit smoking to improve heart function and overall cardiovascular health.\nStorage Instructions\nStore BISOPROLIN 5 in a cool, dry place away from direct sunlight.\nKeep it out of reach of children to avoid accidental ingestion.\nDo not use the medication after the expiration date printed on the package.\nConclusion\nBISOPROLIN 5 is an effective treatment option for managing hypertension, chronic heart failure, angina, and arrhythmias. By improving heart function, lowering blood pressure, and reducing symptoms, it helps enhance the quality of life for patients with cardiovascular conditions. Always follow your doctor’s instructions regarding dosage, administration, and monitoring for the best outcomes.\n\n\n\n\n\n\n\n\n", "price": 65.0, "discountamount": 20.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "warnings 1", "bisoprolin 5", "helps prevent", "manages hypertension", "patients suffering", "helps enhance", "shock 2 pregnancy", "extra monitoring", "optimal results", "usual dose", "breath swelling", "commonly prescribed", "medication bisoprolin 5", "lifethreatening complications", "complications key", "reducing symptoms", "bisoprolol 5mg", "breastfeeding bisoprolin 5", "bisoprolin 5 antidepressants", "water bisoprolin 5", "impaired bisoprolin 5", "medication abruptly", "hearts workload", "reduce symptoms", "direct sunlight", "breastfeeding mothers", "taking precautions", "overthecounter drugs", "medications supplements", "psychiatric medications", "ace inhibitors", "antihypertensive medications", "medications affecting", "persistent nausea", "liver problems", "face lips", "experienced rare", "treatment dizziness", "initial stages", "healthcare provider", "stop taking", "doctors instructions", "vary depending", "primarily affects", "atrial fibrillation", "stable angina", "preventing episodes", "managing angina", "hearts ability", "kidney damage", "frequently prescribed", "essential component", "bisoprolol insulin", "heart block", "heart beat", "heart contractions", "angina dosage", "angina attacks", "treat conditions", "electrical activity", "pump blood", "kidney function", "heart attacks", "side effects", "dosage administration", "cardiovascular conditions", "heart rate", "heart function", "cardiovascular events", "heart failure", "blood pressure", "common effect", "administration recommended dosage", "lowering heart rate", "heart attacks strokes", "reducing blood pressure", "severe cardiovascular events", "cardiovascular conditions bisoprolol", "highly effective medication", "heart failure symptoms", "common side effects", "hearts oxygen demand", "dietary tips follow", "reduce potential interactions", "common side effect", "effective treatment option", "reduced heart rate", "improve heart function", "heart rate drops", "respiratory disorders individuals", "uncontrolled heart failure", "receptors bisoprolol reduces", "blood pressurelowering effect", "lower blood pressure", "heart rhythm disorders", "heart attack stroke", "avoid strenuous activity", "hearts beta1 receptors", "insufficient blood flow", "common drug interactions", "expiration date printed", "avoid accidental ingestion", "cool dry place", "limited salt intake", "healthy balanced diet", "checked periodically lifestyle", "calcium channel blockers", "jaundice dark urine", "feel cold due", "ensure consistency swallow", "individual patient response", "improves exercise tolerance", "chest pain caused", "blocking beta1 receptors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2039, "imageuri": "https://productimages.withfloats.com/actual/679757d6b85fd002599105ef.png", "tileimageuri": "https://productimages.withfloats.com/tile/679757d6b85fd002599105ef.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-01-27T09:53:30.652Z", "updatedon": "2025-01-29T12:01:30.749Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/bisoprolol-5mg-/2039", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "BISOPROLIN 5 ", "category": "cardiology ", "tags": [ "Bisoprolol 5 mg uses", "Bisoprolol 5 mg price in India", "Is 5 mg of bisoprolol a low dose", "Bisoprolol fumarate 5 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e8611b9f7300708fe1240", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRIOGLIMITERIS 1/0.2 ", "description": "TRIOGLIMITERIS 1/0.2 \nVoglibose 0.2 mg, Glimepiride 1 mg & Metformin Hydrochloride 500 mg\nIntroduction\n\nTRIOGLIMITERIS 1/0.2 is a combination medication containing Voglibose, Glimepiride, and Metformin Hydrochloride. It is primarily used in the management of type 2 diabetes mellitus to improve glycemic control through different mechanisms of action targeting glucose metabolism.\n\nComposition\n\nVoglibose (0.2 mg): An alpha-glucosidase inhibitor that delays the digestion of carbohydrates in the intestine, thereby reducing postprandial blood glucose levels.\nGlimepiride (1 mg): A sulfonylurea derivative that stimulates insulin release from pancreatic beta cells, enhancing glucose uptake in peripheral tissues.\nMetformin Hydrochloride (500 mg): A biguanide that decreases hepatic glucose production, improves insulin sensitivity in peripheral tissues, and reduces intestinal glucose absorption.\nMechanism of Action\n\nTRIOGLIMITERIS 1/0.2 combines the actions of its components to achieve optimal glycemic control:\n\nVoglibose: Inhibits alpha-glucosidase enzymes in the intestine, delaying carbohydrate digestion and reducing the absorption of glucose after meals.\nGlimepiride: Stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner, thereby lowering blood glucose levels.\nMetformin Hydrochloride: Decreases hepatic glucose production through suppression of gluconeogenesis and enhances peripheral glucose uptake and utilization by improving insulin sensitivity.\nIndications\n\nTRIOGLIMITERIS 1/0.2 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults when diet, exercise, and monotherapy with metformin or sulfonylureas alone are not sufficient.\nDosage and Administration\n\nThe typical dosage of TRIOGLIMITERIS 1/0.2 is one tablet taken orally with meals, usually once or twice daily.\nDosage adjustments may be required based on individual patient response, blood glucose levels, and renal function.\nIt is essential to adhere to the prescribed dosage regimen to achieve optimal therapeutic outcomes.\nSide Effects\n\nCommon side effects of TRIOGLIMITERIS 1/0.2 may include:\n\nHypoglycemia (especially when used in combination with insulin or other antidiabetic medications)\nGastrointestinal disturbances (such as nausea, vomiting, diarrhea, or abdominal discomfort)\nWeight gain (mainly associated with sulfonylureas)\nMore severe side effects can include:\n\nAllergic reactions (rash, itching, swelling)\nLactic acidosis (rare but serious adverse effect associated with metformin use)\nHepatic dysfunction (monitor liver function tests periodically)\nPrecautions\n\nUse with caution in patients with renal impairment, hepatic dysfunction, or other significant medical conditions that may affect drug metabolism or excretion.\nRegular monitoring of blood glucose levels, renal function, and liver function is recommended during treatment with TRIOGLIMITERIS 1/0.2.\nAvoid use in patients with type 1 diabetes mellitus or diabetic ketoacidosis.\nDrug Interactions\n\nTRIOGLIMITERIS 1/0.2 may interact with other medications affecting blood glucose levels, such as insulin, other oral antidiabetic agents, or drugs that affect renal function or hepatic metabolism. Close monitoring and dose adjustments may be necessary.\nConclusion\n\nTRIOGLIMITERIS 1/0.2 provides a comprehensive approach to managing type 2 diabetes mellitus by combining Voglibose, Glimepiride, and Metformin Hydrochloride. This combination targets different aspects of glucose metabolism, enhancing insulin secretion, reducing hepatic glucose production, and delaying carbohydrate absorption in the intestine. Proper dosage, administration, and monitoring for side effects are essential to achieve and maintain optimal glycemic control in diabetic patients using TRIOGLIMITERIS 1/0.2. Consultation with a healthcare provider is recommended for personalized treatment plans and management of diabetes with this medication.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 195.0, "discountamount": 58.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "500 mg", "0.2 mg", "one tablet", "Weight gain", "Glimepiride 1", "metformin use", "Proper dosage", "Glimepiride (1", "dosage regimen", "typical dosage", "renal function", "insulin release", "drug metabolism", "Lactic acidosis", "Close monitoring", "dose adjustments", "renal impairment", "diabetic patients", "insulin secretion", "different aspects", "Drug Interactions", "other medications", "Regular monitoring", "Dosage adjustments", "Allergic reactions", "peripheral tissues", "hepatic metabolism", "glucose metabolism", "insulin sensitivity", "healthcare provider", "Hepatic dysfunction", "Common side effects", "abdominal discomfort", "different mechanisms", "liver function tests", "diabetic ketoacidosis", "pancreatic beta cells", "combination medication", "carbohydrate digestion", "comprehensive approach", "serious adverse effect", "Metformin Hydrochloride", "carbohydrate absorption", "sulfonylurea derivative", "glucose-dependent manner", "optimal glycemic control", "type 1 diabetes mellitus", "type 2 diabetes mellitus", "More severe side effects", "alpha-glucosidase enzymes", "peripheral glucose uptake", "hepatic glucose production", "alpha-glucosidase inhibitor", "individual patient response", "personalized treatment plans", "optimal therapeutic outcomes", "Gastrointestinal disturbances", "intestinal glucose absorption", "other antidiabetic medications", "other oral antidiabetic agents", "postprandial blood glucose levels", "other significant medical conditions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1939, "imageuri": "https://productimages.withfloats.com/actual/668e86143a68154e11e7d822.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e86143a68154e11e7d822.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T13:01:05.875Z", "updatedon": "2024-07-10T13:01:05.875Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trioglimiteris-1-0-2-/1939", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRIOGLIMITERIS 1/0.2 ", "category": "DIABETIC RANGE", "tags": [ "glimepiride 1mg+metformin 500mg+voglibose 0.2 mg", "Glimepiride 2mg Metformin 500mg Voglibose 0.2 mg b", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg", "voglibose glimepiride & metformin hydrochloride (s", "voglibose glimepiride + metformin hydrochloride us", "glimepiride 1mg+metformin 500mg+voglibose 0.3 mg", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg g", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e77e853fc1c2298508399", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TENELIGOLD PIO 20/15 ", "description": "TENELIGOLD PIO 20/15 \nTeneligliptin & Pioglitazone\nIntroduction\nTENELIGOLD PIO 20/15 combines two antidiabetic medications, Teneligliptin and Pioglitazone, in a single formulation. This combination is designed to manage type 2 diabetes mellitus by targeting different aspects of glucose metabolism, thereby improving glycemic control in patients who are inadequately controlled with monotherapy or require dual therapy.\n\nComposition\n\nTeneligliptin: A dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and reduces glucagon release, thereby lowering blood glucose levels.\nPioglitazone: A thiazolidinedione (TZD) that improves insulin sensitivity in peripheral tissues (muscle and adipose tissue) and reduces hepatic glucose production.\nMechanism of Action\n\nTeneligliptin: Inhibits the degradation of incretin hormones (GLP-1 and GIP), which play a key role in glucose-dependent insulin secretion and suppression of glucagon secretion.\nPioglitazone: Activates peroxisome proliferator-activated receptor gamma (PPAR-γ), leading to improved insulin sensitivity, enhanced glucose uptake in peripheral tissues, and reduced hepatic glucose production.\nIndications\nTENELIGOLD PIO 20/15 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults who are inadequately controlled with diet and exercise alone or with other antidiabetic medications.\nDosage and Administration\n\nThe typical dosage is one tablet of TENELIGOLD PIO 20/15 taken orally once daily, preferably with meals.\nDosage adjustments may be necessary based on individual patient response and tolerability.\nIt is important to adhere to the prescribed dosage regimen to achieve optimal glycemic control.\nSide Effects\nCommon side effects may include:\n\nHypoglycemia (especially when used in combination with insulin or sulfonylureas)\nEdema (fluid retention)\nWeight gain\nHeadache\nNasopharyngitis (common cold)\nMore severe side effects can include:\n\nHeart failure (especially in patients with pre-existing cardiovascular disease)\nHepatic dysfunction (monitor liver function tests periodically)\nBone fractures (especially in women)\nPrecautions\n\nHeart Failure: Use with caution in patients with a history of heart failure or other cardiovascular diseases.\nBladder Cancer: Pioglitazone has been associated with an increased risk of bladder cancer; therefore, it should be used cautiously in patients with a history of bladder cancer or with risk factors.\nLiver Function: Monitor liver function tests before starting treatment and periodically thereafter, as Pioglitazone may cause hepatic dysfunction.\nPregnancy and Lactation: Use during pregnancy and lactation should be avoided unless the potential benefits outweigh the risks.\nDrug Interactions\n\nInsulin/Sulfonylureas: Increased risk of hypoglycemia when used concomitantly with insulin or sulfonylureas.\nGemfibrozil: May increase Pioglitazone levels, requiring dose adjustment.\nCYP2C8 Inhibitors (e.g., Gemfibrozil): May increase Pioglitazone concentrations, necessitating monitoring for adverse effects.\nConclusion\nTENELIGOLD PIO 20/15 offers a dual-action approach to managing type 2 diabetes mellitus by combining Teneligliptin and Pioglitazone. This combination helps improve glycemic control through different mechanisms: enhancing insulin secretion and sensitivity. It is crucial to use this medication under the guidance of a healthcare professional to optimize treatment outcomes while minimizing the risk of side effects. Regular monitoring for efficacy and safety parameters, including blood glucose levels and potential adverse effects, is essential for managing diabetes effectively with TENELIGOLD PIO 20/15.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n", "price": 149.0, "discountamount": 44.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "key role", "one tablet", "Weight gain", "common cold", "risk factors", "dual therapy", "Heart failure", "increased risk", "dosage regimen", "typical dosage", "Bladder Cancer", "Bone fractures", "adipose tissue", "TENELIGOLD PIO", "glucose uptake", "dose adjustment", "fluid retention", "glucagon release", "DPP-4) inhibitor", "safety parameters", "CYP2C8 Inhibitors", "Drug Interactions", "incretin hormones", "different aspects", "Regular monitoring", "treatment outcomes", "Dosage adjustments", "peripheral tissues", "single formulation", "glucagon secretion", "potential benefits", "glucose metabolism", "insulin sensitivity", "Pioglitazone levels", "Hepatic dysfunction", "Common side effects", "different mechanisms", "dual-action approach", "liver function tests", "blood glucose levels", "dipeptidyl peptidase-4", "healthcare professional", "optimal glycemic control", "type 2 diabetes mellitus", "More severe side effects", "potential adverse effects", "hepatic glucose production", "Pioglitazone concentrations", "individual patient response", "two antidiabetic medications", "other cardiovascular diseases", "other antidiabetic medications", "existing cardiovascular disease", "glucose-dependent insulin secretion", "peroxisome proliferator-activated receptor gamma" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1935, "imageuri": "https://productimages.withfloats.com/actual/668e77ebf07c99c3af8e6d67.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e77ebf07c99c3af8e6d67.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T12:00:40.528Z", "updatedon": "2024-07-10T12:00:40.528Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/teneligold-pio-20-15-/1935", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TENELIGOLD PIO 20/15 ", "category": "DIABETIC RANGE", "tags": [ "teneligliptin + pioglitazone brand name", "Zita Plus Pio", "Teneligliptin + Pioglitazone Metformin", "Zita Piomet 1000", "Teneligliptin 20 MG and Pioglitazone 15 MG tablets", "Dapagliflozin", "Zita Piomet 500" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e6a917a3a9f14c496085b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "FLOCLOVIR 250 ", "description": "FLOCLOVIR 250 \nFamciclovir (250mg)\nIntroduction\nFLOCLOVIR 250 is an antiviral medication containing Famciclovir (250mg), primarily used to treat infections caused by herpes viruses, including herpes zoster (shingles), genital herpes, and cold sores. Famciclovir is a prodrug that is converted into penciclovir in the body, which then inhibits viral DNA replication, reducing the severity and duration of outbreaks.\n\nComposition\n\nFamciclovir (250mg): An antiviral agent that is effective against herpes simplex virus (HSV) types 1 and 2 and varicella-zoster virus (VZV).\nMechanism of Action\nFamciclovir is converted to penciclovir in the body. Penciclovir works by inhibiting the viral DNA polymerase enzyme, which is necessary for viral DNA synthesis and replication. By blocking this enzyme, penciclovir prevents the virus from multiplying, thereby controlling the infection and reducing symptoms.\n\nIndications\nFLOCLOVIR 250 is indicated for the treatment of:\n\nHerpes Zoster (Shingles): To reduce pain and accelerate healing of shingles rashes.\nGenital Herpes: For the treatment of initial and recurrent episodes of genital herpes, as well as for suppressive therapy to reduce the frequency of outbreaks.\nCold Sores (Herpes Labialis): To reduce the severity and duration of cold sores.\nDosage and Administration\n\nHerpes Zoster: The typical dosage is 500mg every 8 hours for 7 days.\nGenital Herpes (Initial Episode): 250mg three times daily for 5-10 days.\nGenital Herpes (Recurrent Episodes): 125mg twice daily for 5 days.\nSuppressive Therapy for Genital Herpes: 250mg twice daily.\nCold Sores: 1500mg as a single dose at the first sign of symptoms.\nDosage adjustments may be necessary for patients with renal impairment. It is crucial to start treatment at the first sign of an outbreak for maximum effectiveness.\nSide Effects\nCommon side effects may include:\n\nHeadache\nNausea\nDiarrhea\nFatigue\nAbdominal pain\nLess common but more severe side effects may include:\n\nAcute renal failure (particularly in patients with pre-existing kidney disease)\nAllergic reactions (rash, itching, swelling, severe dizziness, trouble breathing)\nPrecautions\n\nAllergy: Patients with a known allergy to Famciclovir, penciclovir, or any other components should avoid using this medication.\nRenal Impairment: Dosage adjustments are necessary for patients with kidney problems.\nPregnancy and Lactation: The safety of Famciclovir in pregnant or breastfeeding women has not been fully established. It should only be used if the potential benefits outweigh the risks.\nDrug Interactions\n\nProbenecid: May increase blood levels of Famciclovir, leading to increased risk of side effects.\nOther Antivirals: Combining with other antiviral drugs may enhance therapeutic effects but also increase the risk of side effects.\nConclusion\nFLOCLOVIR 250, with its active ingredient Famciclovir, provides an effective treatment option for managing herpes virus infections. By inhibiting viral replication, it helps reduce the severity and duration of outbreaks, offering relief to patients suffering from herpes zoster, genital herpes, and cold sores. As with any medication, it is essential to use FLOCLOVIR 250 as prescribed by a healthcare professional and to consult a doctor for any concerns or potential drug interactions. Proper use ensures optimal outcomes and minimizes the risk of side effects.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 312.0, "discountamount": 93.6, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "5 days", "7 days", "5-10 days", "Proper use", "first sign", "cold sores", "single dose", "Less common", "blood levels", "herpes zoster", "Abdominal pain", "typical dosage", "genital herpes", "herpes viruses", "shingles rashes", "Initial Episode", "Herpes Labialis", "antiviral agent", "kidney problems", "optimal outcomes", "Diarrhea Fatigue", "Other Antivirals", "other components", "renal impairment", "severe dizziness", "active ingredient", "viral replication", "Dosage adjustments", "Allergic reactions", "recurrent episodes", "potential benefits", "breastfeeding women", "suppressive therapy", "therapeutic effects", "severe side effects", "Common side effects", "Acute renal failure", "viral DNA synthesis", "antiviral medication", "herpes simplex virus", "maximum effectiveness", "other antiviral drugs", "viral DNA replication", "varicella-zoster virus", "healthcare professional", "herpes virus infections", "existing kidney disease", "effective treatment option", "potential drug interactions", "viral DNA polymerase enzyme" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1930, "imageuri": "https://productimages.withfloats.com/actual/668e6a94f07c99c3af8e5671.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e6a94f07c99c3af8e5671.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T11:03:45.437Z", "updatedon": "2024-07-10T11:03:45.437Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/floclovir-250-/1930", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "FLOCLOVIR 250 ", "category": "GENERAL RANGE", "tags": [ "Famciclovir 250mg dosage", "What is famciclovir 500 mg used for", "Famciclovir 250 mg price", "Famciclovir 500 mg dosage", "Is famciclovir an antibiotic", "Famciclovir side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e670cc6d2d31770978860", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CEFEXOTIME DICLOXA ", "description": "CEFEXOTIME DICLOXA \nCefixime (200mg), Dicloxacillin ER (500mg)\nIntroduction\nCEFEXOTIME DICLOXA is a potent antibiotic combination therapy that includes Cefixime (200mg) and Dicloxacillin ER (500mg). This medication is designed to combat a broad spectrum of bacterial infections, leveraging the synergistic effects of both antibiotics to enhance efficacy.\n\nComposition\n\nCefixime (200mg): A third-generation cephalosporin antibiotic known for its broad-spectrum activity against Gram-positive and Gram-negative bacteria. It works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death.\nDicloxacillin ER (500mg): An extended-release form of dicloxacillin, a penicillinase-resistant penicillin. It is particularly effective against penicillinase-producing staphylococci and works by inhibiting cell wall synthesis.\nMechanism of Action\n\nCefixime: It binds to penicillin-binding proteins (PBPs) within the bacterial cell wall, disrupting the cross-linking of peptidoglycan chains necessary for cell wall strength and rigidity, resulting in cell lysis.\nDicloxacillin: It similarly binds to PBPs, preventing the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, which is crucial for maintaining cell wall integrity.\nIndications\nCEFEXOTIME DICLOXA is indicated for the treatment of various bacterial infections, including:\n\nRespiratory tract infections (e.g., bronchitis, pneumonia)\nUrinary tract infections (UTIs)\nSkin and soft tissue infections\nOtitis media\nSinusitis\nBone and joint infections\nDosage and Administration\nThe typical dosage for adults is one tablet taken twice daily, with or without food. The duration of treatment depends on the severity and type of infection, usually ranging from 7 to 14 days. It is essential to complete the full course of therapy to prevent the development of antibiotic-resistant bacteria.\n\nSide Effects\nCommon side effects may include:\n\nGastrointestinal disturbances (nausea, vomiting, diarrhea)\nAllergic reactions (rash, itching, anaphylaxis in severe cases)\nPseudomembranous colitis\nHepatic dysfunction (elevated liver enzymes)\nHematologic effects (eosinophilia, neutropenia)\nRenal toxicity (in rare cases)\nPrecautions\n\nAllergy: Patients with a history of allergic reactions to cephalosporins, penicillins, or any other beta-lactam antibiotics should use this medication with caution.\nRenal Impairment: Dose adjustment may be necessary for patients with renal dysfunction.\nPregnancy and Lactation: The safety of this medication in pregnant and breastfeeding women has not been fully established. It should only be used if clearly needed and prescribed by a healthcare provider.\nDrug Interactions\n\nProbenecid: May increase blood levels of Cefixime.\nWarfarin: Concomitant use can enhance anticoagulant effects, increasing the risk of bleeding.\nMethotrexate: Cefixime may reduce renal clearance of methotrexate, increasing its toxicity.\nOral Contraceptives: Antibiotics may reduce the efficacy of oral contraceptives, suggesting the need for additional contraceptive measures.\nConclusion\nCEFEXOTIME DICLOXA, with its combination of Cefixime and Dicloxacillin, provides a robust treatment option for various bacterial infections. Its broad-spectrum efficacy, combined with the extended-release formulation, ensures a potent and convenient antibiotic therapy. As with all antibiotics, it is crucial to use this medication as prescribed and complete the full course to prevent the emergence of resistant bacteria and achieve optimal therapeutic outcomes. Always consult with a healthcare professional before starting any new medication.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n", "price": 395.0, "discountamount": 118.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "rare cases", "one tablet", "cell lysis", "full course", "blood levels", "severe cases", "7 to 14 days", "Otitis media", "new medication", "Renal toxicity", "typical dosage", "broad spectrum", "renal clearance", "Concomitant use", "Dose adjustment", "Dicloxacillin ER", "Renal Impairment", "joint infections", "Drug Interactions", "renal dysfunction", "Allergic reactions", "CEFEXOTIME DICLOXA", "cell wall strength", "Oral Contraceptives", "healthcare provider", "breastfeeding women", "Hepatic dysfunction", "Hematologic effects", "synergistic effects", "Common side effects", "cell wall integrity", "peptidoglycan chains", "bacterial cell walls", "extended-release form", "anticoagulant effects", "Gram-negative bacteria", "soft tissue infections", "elevated liver enzymes", "broad-spectrum efficacy", "healthcare professional", "broad-spectrum activity", "peptidoglycan synthesis", "robust treatment option", "Pseudomembranous colitis", "Urinary tract infections", "penicillin-binding proteins", "final transpeptidation step", "Respiratory tract infections", "various bacterial infections", "optimal therapeutic outcomes", "Gastrointestinal disturbances", "antibiotic-resistant bacteria", "other beta-lactam antibiotics", "convenient antibiotic therapy", "bacterial cell wall synthesis", "additional contraceptive measures", "penicillinase-resistant penicillin", "penicillinase-producing staphylococci", "potent antibiotic combination therapy", "third-generation cephalosporin antibiotic" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1928, "imageuri": "https://productimages.withfloats.com/actual/668e670f4e0af60ab3e5e128.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e670f4e0af60ab3e5e128.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T10:48:44.065Z", "updatedon": "2024-07-10T10:48:44.065Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cefexotime-dicloxa-/1928", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CEFEXOTIME DICLOXA ", "category": "GENERAL RANGE", "tags": [ "Cefixime and Dicloxacillin tablets Uses in Hindi", "Cefixime+Dicloxacillin er tablets", "", "Cefixime and Dicloxacillin uses", "Cefixime Dicloxacillin and lactic acid bacillus ta", "", "Cefixime + Dicloxacillin and Lactic acid bacillus ", "Cefixime Dicloxacillin mr and lactic acid bacillus", "Cefixime and Dicloxacillin tablets side effects", "Cefixime dicloxacillin tablet uses in tamil" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668d24ff75f1701d34699e32", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLICLAGLAZE 80 ", "description": "GLICLAGLAZE 80 \nGliclazide (80mg)\nOverview\nGLICLAGLAZE 80 is an oral medication containing Gliclazide at a dosage of 80 mg. Gliclazide belongs to the class of drugs known as sulfonylureas and is primarily used to manage type 2 diabetes mellitus. It helps control blood sugar levels by stimulating the release of insulin from the pancreatic beta cells. GLICLAGLAZE 80 is an effective treatment option for individuals who require oral hypoglycemic therapy to maintain optimal blood glucose levels.\n\nBenefits of Gliclazide\n\nBlood Sugar Control\n\nGliclazide effectively lowers blood glucose levels by increasing insulin secretion.\nHelps prevent complications associated with diabetes, such as neuropathy, nephropathy, and retinopathy.\nReduced Risk of Hypoglycemia\n\nCompared to some other sulfonylureas, Gliclazide has a lower risk of causing hypoglycemia (low blood sugar levels).\nIt provides a balanced approach to managing blood sugar without causing excessive drops in glucose levels.\nCardiovascular Benefits\n\nStudies suggest that Gliclazide may have a protective effect on the cardiovascular system.\nIt may reduce the risk of cardiovascular events in diabetic patients, promoting overall heart health.\nImproved Glycemic Control\n\nHelps achieve and maintain target HbA1c levels, reflecting long-term glycemic control.\nCan be used in combination with other oral antidiabetic agents or insulin to enhance its effectiveness.\nUsage and Dosage\nGLICLAGLAZE 80 should be taken as prescribed by a healthcare professional. The typical starting dose is 40 to 80 mg daily, which can be adjusted based on the patient's blood glucose response. It is usually taken with meals to maximize its effectiveness and minimize gastrointestinal side effects. Consistent use and adherence to prescribed dosage are crucial for optimal results.\n\nIndications for Use\n\nType 2 Diabetes Mellitus: GLICLAGLAZE 80 is indicated for the management of type 2 diabetes in patients who cannot achieve adequate glycemic control through diet and exercise alone.\nCombination Therapy: It can be used in conjunction with other oral hypoglycemic agents or insulin to achieve better blood sugar control.\nSide Effects\nGLICLAGLAZE 80 is generally well-tolerated. However, some patients may experience side effects, including:\n\nHypoglycemia: Although less common, low blood sugar can occur, especially if meals are skipped or combined with excessive physical activity.\nGastrointestinal Issues: Nausea, abdominal pain, and diarrhea may occur but are usually mild and transient.\nAllergic Reactions: Rarely, allergic reactions such as skin rash, itching, or hives may occur.\nPrecautions and Contraindications\n\nLiver and Kidney Impairment: Patients with severe liver or kidney disease should use GLICLAGLAZE 80 with caution, as it may require dose adjustments.\nPregnancy and Lactation: Gliclazide is not recommended during pregnancy or breastfeeding. Alternative treatments should be considered.\nDrug Interactions: Inform your healthcare provider about all medications and supplements you are taking, as Gliclazide can interact with other drugs, potentially altering its effectiveness.\nConclusion\nGLICLAGLAZE 80 is a reliable and effective oral medication for managing type 2 diabetes mellitus. By stimulating insulin secretion, it helps control blood sugar levels, reducing the risk of diabetes-related complications. Its balanced approach to glycemic control, combined with potential cardiovascular benefits, makes GLICLAGLAZE 80 a valuable addition to diabetes management plans. Under the guidance of a healthcare professional, GLICLAGLAZE 80 can significantly improve the quality of life for individuals with type 2 diabetes, promoting better long-term health outcomes.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 265.0, "discountamount": 79.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "skin rash", "lower risk", "40 to 80 mg", "other drugs", "severe liver", "Reduced Risk", "Consistent use", "kidney disease", "abdominal pain", "excessive drops", "optimal results", "dose adjustments", "diabetic patients", "insulin secretion", "valuable addition", "Drug Interactions", "Kidney Impairment", "protective effect", "balanced approach", "Allergic Reactions", "healthcare provider", "Combination Therapy", "other sulfonylureas", "Blood Sugar Control", "target HbA1c levels", "overall heart health", "cardiovascular events", "cardiovascular system", "typical starting dose", "pancreatic beta cells", "Alternative treatments", "blood glucose response", "low blood sugar levels", "healthcare professional", "Gastrointestinal Issues", "type 2 diabetes mellitus", "diabetes management plans", "adequate glycemic control", "effective oral medication", "long-term health outcomes", "oral hypoglycemic therapy", "long-term glycemic control", "effective treatment option", "excessive physical activity", "optimal blood glucose levels", "gastrointestinal side effects", "diabetes-related complications", "other oral hypoglycemic agents", "other oral antidiabetic agents", "potential cardiovascular benefits" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1922, "imageuri": "https://productimages.withfloats.com/actual/668d2505c34ba6457aa3fb4d.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668d2505c34ba6457aa3fb4d.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-09T11:54:39.186Z", "updatedon": "2024-07-09T11:54:39.186Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gliclaglaze-80-/1922", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLICLAGLAZE 80 ", "category": "DIABETIC RANGE", "tags": [ "Gliclazide 80mg side effects", "Gliclazide 80mg dosage", "Gliclazide 80mg Metformin 500mg", "Gliclazide 80mg price", "Gliclazide 80mg uses", "Gliclazide 80mg Uses in Hindi", "Gliclazide 80mg before or after meal" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666ade9b162db0236048afc0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PROPENOL PLUS ", "description": "PROPENOL PLUS \nPropranolol, Flunarizine\nIntroduction:\n\nPROPENOL PLUS combines two potent medications, Propranolol and Flunarizine, to offer comprehensive treatment for cardiovascular conditions and migraine headaches. This combination enhances therapeutic efficacy by addressing multiple aspects of these health concerns.\nKey Features and Benefits:\n\nPropranolol (Beta-Blocker):\n\nCardiovascular Benefits: Propranolol is a beta-blocker that effectively manages hypertension, angina, and arrhythmias by reducing heart rate and blood pressure.\nAnxiety Relief: It also helps alleviate anxiety symptoms by blocking the effects of adrenaline, leading to a calmer physiological response.\nMigraine Prevention: Propranolol is beneficial in preventing migraine headaches, reducing their frequency, severity, and duration.\nFlunarizine (Calcium Channel Blocker):\n\nMigraine Prophylaxis: Flunarizine acts as a calcium channel blocker, reducing the frequency and severity of migraine attacks by stabilizing blood vessels and decreasing their hyperactivity.\nVertigo Management: It is also effective in managing vertigo associated with vestibular disorders.\nDual Action:\n\nComprehensive Treatment: PROPENOL PLUS provides a comprehensive approach to managing both cardiovascular conditions and migraines, offering convenience and improved therapeutic outcomes.\nSynergistic Effects: The combination of Propranolol and Flunarizine may have synergistic effects, enhancing their individual benefits and reducing the need for multiple medications.\nDosage and Administration:\n\nDosage Regimen: The recommended dosage of PROPENOL PLUS may vary based on the patient's condition and response to treatment.\nIndividual Components: Propranolol is typically initiated at 40mg two to three times daily for cardiovascular indications and anxiety. Flunarizine is commonly prescribed at 5-10mg daily for migraine prophylaxis.\nCombination Therapy: PROPENOL PLUS combines these dosages into a single formulation, simplifying the treatment regimen and improving patient compliance.\nAdministration: Take PROPENOL PLUS as directed by your healthcare provider, preferably with water and without food to enhance absorption. Follow the prescribed dosage schedule for optimal therapeutic benefits.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/propenol-plus-134108", "price": 175.0, "discountamount": 52.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "food", "40mg", "need", "EMAIL", "water", "angina", "5-10mg", "product", "dosages", "severity", "duration", "frequency", "migraines", "heart rate", "absorption", "adrenaline", "Flunarizine", "convenience", "Propranolol", "Dual Action", "information", "arrhythmias", "Introduction", "Beta-Blocker", "hypertension", "sterispharma", "Key Features", "sterisonline", "PROPENOL PLUS", "blood vessels", "hyperactivity", "CALL/WHATSAPP", "Administration", "Anxiety Relief", "blood pressure", "Dosage Regimen", "health concerns", "dosage schedule", "anxiety symptoms", "multiple aspects", "migraine attacks", "treatment regimen", "migraine headaches", "Vertigo Management", "recommended dosage", "patient compliance", "single formulation", "Synergistic Effects", "individual benefits", "Combination Therapy", "Migraine Prevention", "healthcare provider", "multiple medications", "vestibular disorders", "Migraine Prophylaxis", "therapeutic efficacy", "therapeutic outcomes", "Individual Components", "comprehensive approach", "two potent medications", "Cardiovascular Benefits", "comprehensive treatment", "Calcium Channel Blocker", "cardiovascular conditions", "cardiovascular indications", "optimal therapeutic benefits", "calmer physiological response" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1880, "imageuri": "https://productimages.withfloats.com/actual/666ade9f897f5154474a36d4.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666ade9f897f5154474a36d4.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T11:57:15.921Z", "updatedon": "2024-06-26T07:43:42.75Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/propenol-plus-/1880", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PROPENOL PLUS ", "category": "NEUROLOGY RANGE", "tags": [ "PROPENOL PLUS", "Propranolol, Flunarizine", "Flunarizine", "Propranolol side effects", "Propranolol", "Propranolol", "Propranolol" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }